ConductScience.org, home

Paper32047367

Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.

Goldberg JF. Focus (Am Psychiatr Publ), 2019. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. Papers, record 32047367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32047367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.
PubMed
Journal
Focus (Am Psychiatr Publ)
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2024-03-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldberg JFJoseph F

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122163329Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.PLoS One2011https://conductscience.org/library/papers/22163329PubMed
226992156Polypharmacy in Maintenance of Bipolar Disorder.Clin Neuropharmacol2016https://conductscience.org/library/papers/26992156PubMed
327856422Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials.Br J Psychiatry2017https://conductscience.org/library/papers/27856422PubMed
417628508Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.Biol Psychiatry2007https://conductscience.org/library/papers/17628508PubMed
519210946Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.J Clin Psychiatry2009https://conductscience.org/library/papers/19210946PubMed
620122366A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).J Clin Psychiatry2010https://conductscience.org/library/papers/20122366PubMed
721492946The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium.Trends Pharmacol Sci2011https://conductscience.org/library/papers/21492946PubMed
823107222Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.Bipolar Disord2012https://conductscience.org/library/papers/23107222PubMed
916985186The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine.Mol Pharmacol2006https://conductscience.org/library/papers/16985186PubMed
1020092882Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.Lancet2010https://conductscience.org/library/papers/20092882PubMed
1123288387Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.Am J Psychiatry2013https://conductscience.org/library/papers/23288387PubMed
1224170221Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.Am J Psychiatry2014https://conductscience.org/library/papers/24170221PubMed
1330549489A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.J Clin Psychiatry2018https://conductscience.org/library/papers/30549489PubMed
1410826666Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.J Clin Psychiatry2000https://conductscience.org/library/papers/10826666PubMed
1517355728Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians.Curr Med Res Opin2007https://conductscience.org/library/papers/17355728PubMed
1615117400Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.Bipolar Disord2004https://conductscience.org/library/papers/15117400PubMed
1715126120Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus.Brain Res2004https://conductscience.org/library/papers/15126120PubMed
1829536616Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Bipolar Disord2018https://conductscience.org/library/papers/29536616PubMed
1917196048Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.J Clin Psychiatry2006https://conductscience.org/library/papers/17196048PubMed
2018346292A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.Int J Neuropsychopharmacol2008https://conductscience.org/library/papers/18346292PubMed

See all 109 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42541691
Trajectories of psychotropic drug use patterns in psychiatric inpatients with acute depressive episodes of bipolar disorder: results from a pharmacovigilance program in German-speaking countries from 2007 to 2024.
Int J Bipolar Disord2026https://conductscience.org/library/papers/42541691PubMed
42479879Optimizing Treatment Strategies in the Bipolar Disorder Spectrum With Classical AI Approaches: Systematic Review of Performance, Bias, and Clinical Applicability.JMIR Ment Health2026https://conductscience.org/library/papers/42479879PubMed
42351613Pharmacotherapeutic Options in Drug-Resistant Bipolar Depression: From Molecular Mechanisms to Rational Polypharmacotherapy.Biomedicines2026https://conductscience.org/library/papers/42351613PubMed
40649910Plasma and Serum LC-MS Lipidomic Fingerprints of Bipolar Disorder and Schizophrenia.Int J Mol Sci2025https://conductscience.org/library/papers/40649910PubMed
39438154Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus.Bipolar Disord2025https://conductscience.org/library/papers/39438154PubMed
38847247Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder.Curr Pharm Des2024https://conductscience.org/library/papers/38847247PubMed
38765068Benson relaxation technique to address sleep quality and aggression among patients with bipolar type I disorder: A randomized clinical trial study.Heliyon2024https://conductscience.org/library/papers/38765068PubMed
38695001Bipolar Disorder Among Older Adults: Newer Evidence to Guide Clinical Practice.Focus (Am Psychiatr Publ)2023https://conductscience.org/library/papers/38695001PubMed
36825703Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics.Curr Neuropharmacol2023https://conductscience.org/library/papers/36825703PubMed
36269465Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials.Int J Bipolar Disord2022https://conductscience.org/library/papers/36269465PubMed
33623386Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review.Neuropsychiatr Dis Treat2021https://conductscience.org/library/papers/33623386PubMed
32047366Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.Focus (Am Psychiatr Publ)2019https://conductscience.org/library/papers/32047366PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32047367

GET https://conductscience.org/api/papers/v1/32047367/references?page=2